The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer
Open accessAbstract
The therapeutic efficacy of most drugs is greatly depends on their ability to cross the cellular barrier and reach their intracellular target sites. To transport the drugs effectively through the cellular membrane and to deliver them into the intracellular environment, several interesting smart carrier systems based on both synthetic or natural polymers have been designed and developed. In recent years, hyaluronic acid (HA) has emerged as a promising candidate for intracellular delivery of various therapeutic and imaging agents because of its innate ability to recognize specific cellular receptors that overexpressed on diseased cells. The aim of this review is to highlight the significance of HA in cancer, and to explore the recent advances of HA-based drug carriers towards cancer imaging and therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Hyaluronan: its nature, distribution, functions and turnover.
Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00170.x · Cited by 2,031
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Angiogenesis Induced by Degradation Products of Hyaluronic Acid
West, D. C., Hampson, I. N., Arnold, F., & Kumar, S. (1985) · Science · doi:10.1126/science.2408340 · Cited by 1,143
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
THE POLYSACCHARIDE OF THE VITREOUS HUMOR
Meyer, K., & Palmer, J. W. (1934) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)75338-6 · Cited by 1,015
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Hyaluronidases: Their Genomics, Structures, and Mechanisms of Action
Stern, R., & Jedrzejas, M. J. (2006) · Chemical Reviews · doi:10.1021/cr050247k · Cited by 804
Nanomedicine: Developing smarter therapeutic and diagnostic modalities☆
FAROKHZAD, O., & LANGER, R. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.011 · Cited by 800
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology
Cheon, J., & Lee, J.-H. (2008) · Accounts of Chemical Research · doi:10.1021/ar800045c · Cited by 683
Goodison, S., Urquidi, V, & Tarin, D. (1999) · Molecular Pathology · doi:10.1136/mp.52.4.189 · Cited by 679
Stamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
The specific interaction of hyaluronic acid with cartilage proteoglycans.
HARDINGHAM, T., & MUIR, H. (1972) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(72)90160-2 · Cited by 645
Lecticans: organizers of the brain extracellular matrix
Yamaguchi, Y. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000690 · Cited by 642
Weigel, P. H., Hascall, V. C., & Tammi, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.13997 · Cited by 628
Self-assembled hyaluronic acid nanoparticles for active tumor targeting
Choi, K. Y., Chung, H., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.030 · Cited by 578
Self-citationStamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Hyaluronan-binding Proteins: Tying Up the Giant
Day, A. J., & Prestwich, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100036200 · Cited by 567
Naor, D., Nedvetzki, S., Golan, I., Melnik, L., & Faitelson, Y. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795574 · Cited by 557
Goldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., & Butcher, E. C. (1989) · Cell · doi:10.1016/0092-8674(89)90639-9 · Cited by 555
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
Wielenga, V. T., Heider, K., Offerhaus, G. J. A., Adolf, G. R., van den Berg, F. M., Ponta, H., Herrlich, P. A., & Pals, S. T. (1993) · PubMed · Cited by 527
Polymeric nanomedicine for cancer therapy
Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506
Self-citationPolysaccharide-decorated nanoparticles
Lemarchand, C., Gref, R., & Couvreur, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.016 · Cited by 500
Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Ågren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., & Kosma, V.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 493
Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium
Prevo, R., Banerji, S., Ferguson, D. J. P., Clasper, S., & Jackson, D. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011004200 · Cited by 477
HA receptors: Regulators of signalling to the cytoskeleton
Entwistle, J., Hall, C. L., & Turley, E. A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960616)61:4<569::aid-jcb10>3.0.co;2-b · Cited by 472
Hyaluronan and Homeostasis: A Balancing Act
Tammi, M. I., Day, A. J., & Turley, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100037200 · Cited by 462
Bourguignon, L. Y. W., Singleton, P. A., Diedrich, F., Stern, R., & Gilad, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311838200 · Cited by 422
Lectin-mediated drug targeting: history and applications
Bies, C., Lehr, C.-M., & Woodley, J. F. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.030 · Cited by 414
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
Hardwick, C., Hoare, K., Owens, R., Hohn, H., Hook, M., Moore, D., Cripps, V, Austen, L., Nance, D., & Turley, E. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.6.1343 · Cited by 402
Gregoriadis, G. (1977) · Nature · doi:10.1038/265407a0 · Cited by 390
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels
Lee, H., Mok, H., Lee, S., Oh, Y.-K., & Park, T. G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.011 · Cited by 365
CD44 variant exon epitopes in primary breast cancer and length of survival
Kaufmann, M., von Minckwitz, G., Heider, K.-H., Ponta, H., Herrlich, P., & Sinn, H.-P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90521-9 · Cited by 353
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Kim, J.-H., Kim, Y.-S., Park, K., Lee, S., Nam, H. Y., Min, K. H., Jo, H. G., Park, J. H., Choi, K., Jeong, S. Y., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.014 · Cited by 350
Self-citationKim, K., Kim, J. H., Park, H., Kim, Y.-S., Park, K., Nam, H., Lee, S., Park, J. H., Park, R.-W., & Kim, I.-S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.004 · Cited by 347
Self-citationSahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
Choi, K. Y., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., Choi, K., & Jeong, S. Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.010 · Cited by 336
Self-citationTumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Self-citationKosaki, R., Watanabe, K., & Yamaguchi, Y. (1999) · PubMed · Cited by 335
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
Ghatak, S., Misra, S., & Toole, B. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202404200 · Cited by 332
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
Ropponen, K. M., Tammi, M., Parkkinen, J. J., Eskelinen, M., Tammi, R., Lipponen, P., Ågren, U. M., ALHAVA, E. M., & Kosma, V. (1998) · PubMed · Cited by 327
Lee, Y., Lee, H., Kim, Y. B., Kim, J., Hyeon, T., Park, H., Messersmith, P. B., & Park, T. G. (2008) · Advanced Materials · doi:10.1002/adma.200800756 · Cited by 321
Harada, H., & Takahashi, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608358200 · Cited by 320
Upadhyay, K. K., Bhatt, A. N., Mishra, A. K., Dwarakanath, B. S., Jain, S., Schatz, C., Le Meins, J.-F., Farooque, A., Chandraiah, G., Jain, A. K., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.043 · Cited by 316
Kohda, D., Morton, C. J., Parkar, A. A., Hatanaka, H., Inagaki, F. M., Campbell, I. D., & Day, A. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80151-8 · Cited by 309
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
Mulder, J.-W. R., Sewnath, M., Offerhaus, G., Pals, S., Oosting, J., Kruyt, P., Weidema, W., & Seldenrijk, C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90290-9 · Cited by 309
(2024) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-031-52864-4 · Cited by 309
Synthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate
Luo, Y., & Prestwich, G. D. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9900338 · Cited by 305
Lokeshwar, V. B., Rubinowicz, D., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., & Lokeshwar, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008432200 · Cited by 303
Distinct effects of two CD44 isoforms on tumor growth in vivo.
Sy, M. S., Guo, Y. J., & Stamenkovic, I. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.859 · Cited by 298
Lukyanov, A. N., Elbayoumi, T. A., Chakilam, A. R., & Torchilin, V. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.007 · Cited by 294
Schledzewski, K., Falkowski, M., Moldenhauer, G., Metharom, P., Kzhyshkowska, J., Ganss, R., Demory, A., Falkowska‐Hansen, B., Kurzen, H., Ugurel, S., et al. (2006) · The Journal of Pathology · doi:10.1002/path.1942 · Cited by 286
Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis
Hua, Q., Knudson, C. B., & Knudson, W. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.1.365 · Cited by 278
Kaya, G., Rodriguez, I., Jorcano, J. L., Vassalli, P., & Stamenkovic, I. (1997) · Genes & Development · doi:10.1101/gad.11.8.996 · Cited by 274
Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b900456d · Cited by 272
Self-citationHyaluronic Acid−Paclitaxel Conjugate Micelles: Synthesis, Characterization, and Antitumor Activity
Lee, H., Lee, K., & Park, T. G. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000485 · Cited by 266
Identification of the Hyaluronan Receptor for Endocytosis (HARE)
Zhou, B., Weigel, J. A., Fauss, L., & Weigel, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003030200 · Cited by 265
Hyaluronidases in cancer biology
Stern, R. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.017 · Cited by 261 · cited 2×
“Therefore, HA is more rapidly catabolized in malignant tissues [28,69,129].”
Yu, Q., Toole, B. P., & Stamenkovic, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1985 · Cited by 250
Sapra, P., & Allen, T. M. (2002) · PubMed · Cited by 242
De-novo expression of CD44 and survival in gastric cancer
Mayer, B., Jauch, K. W., Schildberg, F. W., Funke, I., Günthert, U., Figdor, C. G., & Johnson, J. P. (1993) · The Lancet · doi:10.1016/0140-6736(93)92879-x · Cited by 238
Hyaluronate and invasiveness of the rabbit V2 carcinoma.
Toole, B. P., Biswas, C., & Gross, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6299 · Cited by 234
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.
Liu, D., Pearlman, E., Diaconu, E., Guo, K., Mori, H., Haqqi, T., Markowitz, S., Willson, J., & Sy, M. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7832 · Cited by 229
Peer, D., & Margalit, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11615 · Cited by 229
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.026 · Cited by 223
LOKESHWAR, V. B., ÖBEK, C., PHAM, H. T., WEI, D., YOUNG, M. J., DUNCAN, R. C., SOLOWAY, M. S., & BLOCK, N. L. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)68050-0 · Cited by 223
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
Stauder, R., Eisterer, W., Thaler, J., & Gunthert, U. (1995) · Blood · doi:10.1182/blood.v85.10.2885.bloodjournal85102885 · Cited by 221
Lokeshwar, V. B., & Selzer, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003084200 · Cited by 216
Inhibition of tumor growthin vivo by hyaluronan oligomers
Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J.-W., & Stamenkovic, I. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6 · Cited by 215
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase
Zhang, S., Chang, M. C. Y., Zylka, D., Turley, S., Harrison, R., & Turley, E. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11342 · Cited by 210
Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis.
Knudson, W., Biswas, C., & Toole, B. P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6767 · Cited by 202
TSG-6: An IL-1 /TNF-inducible protein with anti-inflammatory activity
Wisniewski, H.-G., & Vilĉek, J. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00008-7 · Cited by 200
Lee, H., Lee, K., Kim, I. K., & Park, T. G. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.038 · Cited by 197
CD44 in inflammation and metastasis
Lesley, J., Hyman, R., English, N., Catterall, J. B., & Turner, G. A. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018540610858 · Cited by 194
Hydrotropic Solubilization of Paclitaxel: Analysis of Chemical Structures for Hydrotropic Property
Lee, J., Lee, S. C., Acharya, G., Chang, C.-J., & Park, K. (2003) · Pharmaceutical Research · doi:10.1023/a:1024458206032 · Cited by 189
Self-citationChao, K. L., Muthukumar, L., & Herzberg, O. (2007) · Biochemistry · doi:10.1021/bi700382g · Cited by 187
The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
Assmann, V., Jenkinson, D., Marshall, J. F., & Hart, I. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.22.3943 · Cited by 187
Birch, M., Mitchell, S., & Hart, I. R. (1991) · PubMed · Cited by 182
Koyama, H., Hibi, T., Isogai, Z., Yoneda, M., Fujimori, M., Amano, J., Kawakubo, M., Kannagi, R., Kimata, K., Taniguchi, S., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060793 · Cited by 171
HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor
Lokeshwar, V. B., Cerwinka, W. H., Isoyama, T., & Lokeshwar, B. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1022 · Cited by 171
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
Liu, N., Gao, F., Han, Z. J., Xu, X., Underhill, C. B., & Zhang, L. (2001) · PubMed · Cited by 171
Target Specific Intracellular Delivery of siRNA/PEI−HA Complex by Receptor Mediated Endocytosis
Jiang, G., Park, K., Kim, J., Kim, K. S., & Hahn, S. K. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800176t · Cited by 165
Self-citationLee, H., Ahn, C., & Park, T. G. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800229 · Cited by 163
Bertrand, P., Girard, N., Delpech, B., Duval, C., D'Anjou, J., & Dauce, J. P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520102 · Cited by 160
Simpson, M. A., Wilson, C. M., & McCarthy, J. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64245-9 · Cited by 160
Setälä, L. P., Tammi, M. I., Tammi, R. H., Eskelinen, M. J., Lipponen, P. K., Ågren, U. M., Parkkinen, J., Alhava, E. M., & Kosma, V.-M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690180 · Cited by 159
Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts
Auzenne, E., Ghosh, S. C., Khodadadian, M., Rivera, B., Farquhar, D., Price, R. E., Ravoori, M., Kundra, V., Freedman, R. S., & Klostergaard, J. (2007) · Neoplasia · doi:10.1593/neo.07229 · Cited by 159
Lokeshwar, V. B., Lokeshwar, B. L., Pham, H. T., & Block, N. L. (1996) · PubMed · Cited by 157
Eliaz, R. E., Nir, S., Marty, C., & Szoka, F. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0654 · Cited by 154
Tammi, R., Säämänen, A., Maïbach, H. I., & Tammi, M. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12478553 · Cited by 151
Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Pham, H. T., Block, N. L., & Lokeshwar, V. B. (1997) · PubMed · Cited by 150
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors
Franzmann, E. J., Schroeder, G. L., Goodwin, W. J., Weed, D. T., Fisher, P., & Lokeshwar, V. B. (2003) · International Journal of Cancer · doi:10.1002/ijc.11252 · Cited by 148
Identification of Hyaluronan-binding Domains of Aggrecan
Watanabe, H., Cheung, S. C., Itano, N., Kimata, K., & Yamada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28057 · Cited by 139
Yadav, A. K., Mishra, P., Mishra, A. K., Mishra, P., Jain, S., & Agrawal, G. P. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.09.004 · Cited by 138
Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., & Kimata, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313178200 · Cited by 137
Montesano, R., Kumar, S., Orci, L., & Pepper, M. S. (1996) · PubMed · Cited by 135
Increased hyaluronidase levels in breast tumor metastases
Bertrand, P., Girard, N., Duval, C., d'Anjou, J., Chauzy, C., Ménard, J.-F., & Delpech, B. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<327::aid-ijc4>3.0.co;2-1 · Cited by 135
Simple Primary Structure, Complex Turnover Regulation and Multiple Roles of Hyaluronan
Itano, N. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn046 · Cited by 134
HYAL1 Hyaluronidase: A Molecular Determinant of Bladder Tumor Growth and Invasion
Lokeshwar, V. B., Cerwinka, W. H., & Lokeshwar, B. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2805 · Cited by 126
Ströbel, T., Swanson, L., & Cannistra, S. A. (1997) · PubMed · Cited by 123
Jacobson, A., Rahmanian, M., Rubin, K., & Heldin, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10683 · Cited by 123
Lokeshwar, V. B., Schroeder, G. L., Selzer, M. G., HAUTMANN, S. H., Posey, J., DUNCAN, R. C., Watson, R. B., Rose, L., Markowitz, S. B., & Soloway, M. S. (2002) · Cancer · doi:10.1002/cncr.10652 · Cited by 116
Coradini, D., Pellizzaro, C., Miglierini, G., Daidone, M. G., & Perbellini, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f · Cited by 114
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka, M. A., Okon, E., Gosslar, U., Holzmann, B., & Naor, D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5345 · Cited by 109
Underhill, C. B., & Toole, B. P. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85527-8 · Cited by 108
Correlated metabolism of proteoglycans and hyaluronic acid in bovine cartilage organ cultures.
Morales, T. I., & Hascall, V. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68971-9 · Cited by 104
Underhill, C. B., Green, S. J., Comoglio, P. M., & Tarone, G. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45179-4 · Cited by 103
Yadav, A. K., Mishra, P., Jain, S., Mishra, P., Mishra, A. K., & Agrawal, G. P. (2008) · Journal of drug targeting · doi:10.1080/10611860802095494 · Cited by 103
Rosato, A., Banzato, A., Luca, G. D., Renier, D., Bettella, F., Pagano, C., Esposito, G., Zanovello, P., & Bassi, P. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.08.020 · Cited by 102
In vitro and In vivo Evaluation of Docetaxel Loaded Biodegradable Polymersomes
Upadhyay, K. K., Bhatt, A. N., de Castro, E. D. M., Mishra, A. K., Chuttani, K., Dwarakanath, B. S. R., Schatz, C., Meins, J. L., Misra, A. R., & Lecommandoux, S. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900415 · Cited by 98
Coradini, D., Zorzet, S., Rossin, R., Scarlata, I., Pellizzaro, C., Turrin, C., Bello, M., Cantoni, S., Speranza, A., Sava, G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0349 · Cited by 97
Asplund, T., Versnel, M. A., Laurent, T. C., & Heldin, P. (1993) · PubMed · Cited by 95
Hyaluronidase reduces human breast cancer xenografts in SCID mice
Shuster, S., Frost, G. I., Csoka, A. B., Formby, B., & Stern, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10668 · Cited by 95
Saravanakumar, G., Choi, K. Y., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Park, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.041 · Cited by 95
Self-citationHAUTMANN, S. H., Toma, M. I., Gómez, M. F., Friedrich, M. G., Jäkel, T., Michl, U. H. G., Schroeder, G. L., Huland, H., Juenemann, K., & Lokeshwar, V. B. (2004) · European Urology · doi:10.1016/j.eururo.2004.06.006 · Cited by 94
Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Lokeshwar, V. B., Young, M. J., Goudarzi, G., Iida, N., Yudin, A. I., Cherr, G. N., & Selzer, M. G. (1999) · PubMed · Cited by 94
Expression of CD44 isoforms in renal cell tumors : positive correlation to tumor differentiation
Terpe, H.-J., Störkel, S., Zimmer, U., Anquez, V., Fischer, C. G., Pantel, K., & Günthert, U. (1996) · Europe PMC (PubMed Central) · doi:10.5451/unibas-ep6605 · Cited by 89
Tumor-Derived Hyaluronidase: A Diagnostic Urine Marker for High-Grade Bladder Cancer
Pham, H. T., Block, N. L., & Lokeshwar, V. B. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62975-6 · Cited by 89
Gilg, A. G., Tye, S. L., Tolliver, L. B., Wheeler, W. G., Visconti, R. P., Duncan, J. D., Kostova, F. V., Bolds, L. N., Toole, B. P., & Maria, B. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1228 · Cited by 84
Oishi, M., Tamura, A., Nakamura, T., & Nagasaki, Y. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801164 · Cited by 83
Simpson, M. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060032 · Cited by 79
Tarone, G., Ferracini, R., Galetto, G., & Comoglio, P. M. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.99.2.512 · Cited by 78
Sera of children with renal tumours contain low‐molecular‐mass hyaluronic acid
Kumar, S., West, D. C., Ponting, J., & Gattamaneni, H. R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440311 · Cited by 75
Hyaluronan Oligosaccharides Induce Tube Formation of a Brain Endothelial Cell Linein Vitro☆
Rahmanian, M., Pertoft, H., Kanda, S., Christofferson, R., Claesson‐Welsh, L., & Heldin, P. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3792 · Cited by 71
Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment
Hyung, W., Ko, H., Park, J., Lim, E., Park, S. B., Park, Y., Yoon, H., Suh, J., Haam, S., & Huh, Y. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21578 · Cited by 71
Self-citationExpression of PH-20 in Normal and Neoplastic Breast Tissue
Beech, D. J., Madan, A. K., & Deng, N. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6351 · Cited by 69
Calabro, A. R., Oken, M. M., Hascall, V. C., & Masellis-Smith, A. (2002) · Blood · doi:10.1182/blood-2002-01-0030 · Cited by 69
Kim, Y.-J., Chae, S. Y., Jin, C., Sivasubramanian, M., Son, S., Choi, K. Y., Jo, D., Kim, K., Kwon, I. C., Lee, K. C., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.015 · Cited by 67
Self-citationPerturbation of Hyaluronan Interactions Inhibits Malignant Properties of Glioma Cells
Ward, J. A., Huang, L., Guo, H., Ghatak, S., & Toole, B. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64273-3 · Cited by 63
Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIB
Kainz, C., Kohlberger, P., Sliutz, G., Tempfer, C. M., Heinzl, H., Reinthaller, A., Breitenecker, G., & Koelbl, H. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1159 · Cited by 62
Real Time, High Resolution Video Imaging of Apoptosis in Single Cells with a Polymeric Nanoprobe
Lee, S., Choi, K. Y., Chung, H., Ryu, J. H., Lee, A., Koo, H., 윤인찬, Park, J. H., Kim, S. Y., Kim, S. Y., et al. (2011) · Bioconjugate Chemistry · doi:10.1021/bc1004119 · Cited by 57
Self-citationExpression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata, T., Fukuse, T., Naiki, H., Hitomï, S., & Wada, H. (1998) · PubMed · Cited by 57
Hyaluronidase is more elevated in human brain metastases than in primary brain tumours.
Delpech, B., Laquerrière, A., Maingonnat, C., Bertrand, P., & Fréger, P. (2002) · PubMed · Cited by 52
Victor, R., Chauzy, C., Girard, N., Gioanni, J., d'Anjou, J., de Novion, H. S., & Delpech, B. (1999) · International Journal of Cancer · Cited by 45
Expression and regulation patterns of hyaluronidases in small cell lung cancer and glioma lines.
Junker, N., Latini, S., Petersen, L. N., & Kristjansen, P. E. G. (2003) · PubMed · Cited by 43
Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand
Na, S. J., Chae, S. Y., Lee, S., Park, K., Kim, K., Park, J. H., Kwon, I. C., Jeong, S. Y., & Lee, K. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.013 · Cited by 38
Self-citationHyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma
Christopoulos, T., Papageorgakopoulou, N., Theocharis, D., Mastronikolis, N. S., Papadas, T. A., & Vynios, D. H. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.03.019 · Cited by 34
Bertrand, P., Courel, M., Maingonnat, C., Jardin, F., Tilly, H., & Bastard, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20562 · Cited by 31
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Vasvani, S., Kulkarni, P., & Rawtani, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.066 · Cited by 473
Biomacromolecules as carriers in drug delivery and tissue engineering
Zhang, Y., Sun, T., & Jiang, C. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.11.005 · Cited by 416
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 319
Self-citation
Metadata
- Authors
- Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K.
- Venue
- Colloids and Surfaces B: Biointerfaces
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 99
- Pages
- 82-94
- ISSN
- 0927-7765 (ISSN-L)
- OpenAlex
- W2087473393
- Cited by
- 264
- References
- 155
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.